Disclosures for "Soluble ST2 is associated with neurotoxicity following chimeric antigen receptor T-cell therapy")
-
Miss Fietsam has nothing to disclose.
-
Ms. McKeown has nothing to disclose.
-
Ms. Booraem has nothing to disclose.
-
Ms. Jones has nothing to disclose.
-
Dr. Kimberly has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NControl Therapeutics. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics. Dr. Kimberly has stock in Woolsey Pharmaceuticals. The institution of Dr. Kimberly has received research support from Biogen. The institution of Dr. Kimberly has received research support from NControl Therapeutics. The institution of Dr. Kimberly has received research support from NIH. The institution of Dr. Kimberly has received research support from American Heart Association. Dr. Kimberly has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Jacobson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Kite/Gilead. Dr. Jacobson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/Celgene. Dr. Jacobson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Jacobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for bluebird bio. Dr. Jacobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epizyme. Dr. Jacobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Instil Bio. Dr. Jacobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abintus Bio. Dr. Jacobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Jacobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Caribou Bio. Dr. Jacobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miltenyi. Dr. Jacobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Morphosys. Dr. Jacobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrazeneca. Dr. Jacobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ImmPACT Bio. Dr. Jacobson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for CRICO. Dr. Jacobson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Weitz and Lutz. The institution of Dr. Jacobson has received research support from Kite/Gilead. The institution of Dr. Jacobson has received research support from Pfizer.
-
Dr. Bevers has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO. An immediate family member of Dr. Bevers has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Hinshaw Law. An immediate family member of Dr. Bevers has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Colorado Department of Law. The institution of Dr. Bevers has received research support from NINDS. The institution of an immediate family member of Dr. Bevers has received research support from AHRQ. The institution of Dr. Bevers has received research support from AAN. The institution of an immediate family member of Dr. Bevers has received research support from VIIV. The institution of an immediate family member of Dr. Bevers has received research support from NIH/Kowa Industries.